NIOSHTIC-2 Publications Search
Genetic Testing in the Workplace: Costs and Benefits.
Molecular Dosimetry and Human Cancer: Analytical, Epidemiological, and Social Considerations 1991:401-415
The increased interest in the relationship between genetic markers and the risk of illness may result in more widespread use of genetic testing in the future, raising concerns about the potential social benefits and costs of workplace genetic testing. Specifics discussed included the private benefits and public health impacts of genetic testing, benefits to employers of genetic testing, costs to employers of genetic testing, public versus private costs and benefits, and potential misallocation of genetic testing resources. Several illustrations were offered from data on different kinds of medical screening and monitoring which demonstrated the relationship between the frequency of testing and facility size. From the perspective of the workers exposed to hazardous substances, genetic testing offers the hope of reducing the risk of illness and thus, may be of substantial benefit. However, incentives to screen may be too great for firms with good employment characteristics and too small for firms with poor employment characteristics.
NIOSH-Grant; Grants-other; Genotoxic-effects; Biological-monitoring; Worker-motivation; Safety-practices; Cytotoxic-effects; Genetic-factors; Medical-screening; Risk-factors; Occupational-exposure;
School of Public Health Boston University 80 East Concord Street Boston, MA 02118
Groopman JD; Skipper PL;
Other Occupational Concerns; Grants-other;
Molecular Dosimetry and Human Cancer: Analytical, Epidemiological, and Social Considerations
Boston University, Boston, Massachusetts
Page last reviewed: February 25, 2022Content source: National Institute for Occupational Safety and Health Education and Information Division